Eagle Pharmaceuticals OverviewEagle Pharmaceuticals Gross Profit
Gross Profit analysis for EGRX.
Quarterly Gross Profit
$47.79M
↓ 5.32% YoY
As of Jun 30, 2023
Annual Gross Profit (TTM)
$179.88M
↓ 10.15% YoY
Trailing 12 months ending Jun 30, 2023
Eagle Pharmaceuticals OverviewGross Profit analysis for EGRX.
As of Jun 30, 2023
Trailing 12 months ending Jun 30, 2023